TRxADE HEALTH, Inc. (MEDS) Q1 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to Trixaid Health's first quarter 2022 earnings conference call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be opened for questions. The earnings press release accompanying this conference call was issued at the close of the market today. The quarterly report, which includes additional information regarding the company's Results of operations for the quarter ended March 31, 2022, was filed with the SEC earlier today. On our call today is Trixate Health's founder, chairman, and chief executive officer, Surin Adjirapu, and Janet Huffman, its chief financial officer. The replay of this call and webcast will be available for the next 30 days on the company's website under the NASDAQ Meds link. The company's website also includes more supporting industry information. At this time, I'd like to turn the call over to Janet Huffman, the company's Chief Financial Officer. Janet, the floor is yours. Thank you, Operator, and thank you for joining us today. I'd like to welcome you to our 2022 First Quarter Financial Results Conference Call. Our press release announcing our 2022 First Quarter Financial Results was issued after the close of market today and is posted on our website. We have also furnished such press release to the SEC on Form 8K. Statements made on this call and webcast include forward-looking statements. These statements include, but are not limited to, our outlook for the company and statements that estimate or project future results of operations or the performance of the company. including the potential continued impact of COVID-19 on the company's business and results of operations. These statements speak only as...